Shulman LP

No ORCID on file · 6 papers in corpus
2026
Obstetric Medicine ·doi:10.1177/1753495x251343113

IntroductionCasirivimab/imdevimab (CAS/IMD) comprises two monoclonal antibodies that neutralize SARS-CoV-2. Pregnant individuals were excluded from initial trials, limiting safety data.MethodsThe COVID-19 International Drug Pregnancy Regist…

2021
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-021-02261-7

PurposeThe purpose of this study is to evaluate the perspectives of infertility patients regarding genetic carrier screening, embryo sex selection, embryo research, and gene editing.MethodsAn anonymous 32-question survey was distributed ele…

review 2015
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2015.12.022
review 2015
Human Reproduction Update ·doi:10.1093/humupd/dmv023

BACKGROUND: Most contraceptive methods present benefits beyond contraception; however, despite a large body of evidence, many healthcare professionals (HCPs), users and potential users are unaware of those benefits. This review evaluates th…

article 2011

Jessica W Kiley, Lee P ShulmanSection of Family Planning and Contraception, Department of Obstetrics and Gynecology, Feinberg School of Medicine of Northwestern University, Chicago, IL, USAAbstract: Most combination oral contraceptives cont…

review 2006
Women's health (London, England) ·doi:10.2217/17455057.2.2.191

Depot medroxyprogesterone acetate (DMPA; Depo-Provera) is a highly effective and convenient contraceptive method that has been used worldwide for many decades. Recently, a new lower dose of DMPA, administered as a subcutaneous injection, ha…